TrialJournal of thrombosis and thrombolysis2020

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.

Liping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.